Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00280

Submission Number:
00280
Commenter:
BRANDI BEAN
State:
Louisiana
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
As a pharmacist who has practiced in this profession for the past 13 years have seen a whole lot of evolving issues when it comes to the practice and patient care to pharmacies. When the FTC allows big companies such as CVS and others to purchase other big chains as well as acquire insurances it monopolizes the industry, thus giving an unfair advantage to independent pharmacies. Please do not allow this to happen as it gives patient no options as it comes to their healthcare decisions. While making it hard for smaller companies to survive.